Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Wall Street
Price Targets
Price Targets Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 291.33 CNY with a low forecast of 191.9 CNY and a high forecast of 344.4 CNY.
Price Targets
Revenue
Forecast
Revenue Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 25%. The projected CAGR for the next 4 years is 15%.
Operating Income
Forecast
Operating Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 28%.
Net Income
Forecast
Net Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 20%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price target?
Price Target
291.33
CNY
According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 291.33 CNY with a low forecast of 191.9 CNY and a high forecast of 344.4 CNY.
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 25%. The projected CAGR for the next 4 years is 15%.
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
28%
For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 28%.
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
20%
For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 20%.